Home
Name/Company Name
We’re dedicated to giving you the very best in topic/product, topic/product, and topic/product. Please reach out if you want to know more!
News
- Factor XI Inhibitors: Anticoagulation with Minimal Bleeding?The development of new antithrombotic agents is fundamentally driven by the need to effectively prevent dangerous blood clots (thrombosis) while
- Extended Anticoagulation for Venous ThromboembolismVenous thromboembolism (VTE) encompasses pulmonary embolism and deep vein thrombosis. These conditions carry a significant risk of recurrence, particularly following
- Thrombocytopenia and Venous ThrombosisThrombocytopenia and venous thrombosis present a unique clinical paradox. While low platelet counts typically increase bleeding risk, certain conditions lead
- Paget Schroetter SyndromeSometimes a compression of a vein causes a deep vein thrombosis. The mechanism is by preventing normal blood flow. Stagnant
- Anticoagulation for Peripheral Artery DiseaseStudies have shown that rivaroxaban, an anticogulant marketed as Xarelto, improves outcomes of patients with peripheral artery disease. The concept
